Ref:  PS0059  

Project  Summary   Pharmaceutical  Facility  –  Demolition  Support GlaxoSmithKline  Facility,  Cairo,  Egypt

 

Key  Project  Elements  

• Technical  Review  of  Site  Manual  Demolition    

• Health  and  Safety  Assessment  of  Demolition  Methods  

• Evaluation  of  Demolition  Options  

• Recommendation  of  Safe  Demolition  Methods,  Equipment  and  Contractors

CRA  provided  consultancy  services  to  review  the  current  conditions  of   two  multi-­‐story   concrete   administrative   buildings   that   required  demolition  due  to  deficiencies  of  the  structural  design  to  withstand  local  seismic  loading.  CRA  also  completed  a  technical  and  health  and  safety   review   of   current   Egyptian   demolition   practices   (entirely  manual  labour)  and  evaluated  alternatives  that  might  be  available  in  Egypt  or   could  be  easily   imported   into   the   country   to   facilitate   the  demolition.  Through  the  assessment  of  the  design,  size,  type  of  construction,  and  structural   deficiencies,   CRA   recommended   that   the   structures   be  demolished   using   mechanical   means   to   minimise   direct   and  potentially   fatal   risks   to   human   health,   the   surrounding   property  (including   a   cemetery)   and   GSK   and   third-­‐party   owned   adjacent  structures.     Following   an   assessment   of   options,   and   through   a  detailed   consultation   with   the   Egyptian   contractor,   CRA  recommended   a   safe   demolition   methodology   to   enable   the  Egyptian  contractor   to  safely  demolish   two  multi-­‐story,   reinforced-­‐concrete  buildings.        CRA   further   provided   liaison  between   the  Egyptian   contractor,   the  local  Site  personnel,  and  GSK  corporate  staff  to  facilitate  the  hiring  of  a   European   demolition   expert   company   to   import   equipment   and  labour   to   mechanically   demolish   the   building   using   modern   high  reach  demolition  equipment.  CRA  also  provided  support  to  GSK  with  regards   to   demolition   and   health   and   safety   regulatory  matters   in  context   of   the   Site   location   and   international   best   practice  methodologies.